Elsevier

Brain Research

Volume 501, Issue 1, 30 October 1989, Pages 116-128
Brain Research

Opioid peptides (DAGO-enkephalin, dynorphin A(1–13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla

https://doi.org/10.1016/0006-8993(89)91033-0Get rights and content

Abstract

The highly μ-selective agonist Tyr-d-Ala-Gly-MePhe-Gly-ol-enkephalin (DAGO) produces potent, dose-dependent naloxone-reversible antinociception when microinjected into the ventrolateral periaqueductal gray (PAG) (ED50 = 0.72 nmol) or rostral ventromedial medulla (RVM) (ED50 = 0.50 nmol) as measured on the ratr tail flick (TF) assay. In single-unit recording experiments, DAGO microinjected into the PAG also affected On- and Off-Cell firing in the RVM in the same way as previously demonstrated by our group for morphine. PAG-microinjected DAGO inhibits spontaneous and noxious-evoked On-Cell firing (attenuating the characteristic On-Cell burst) (n=19), and excites spontaneous Off-Cell firing, preventing the characteristic Off-Cell pause (n=12) at doses which suppress the TF. These results support a major role for the μ receptor in PAG and RVM mechanisms of opiate antinociception. In our experiments using BAM22P, an endogenous weakly μ-selective opioid peptide, we could not demonstrate a dose-dependent antinociceptive effect, whether the peptide was microinjected supraspinally into the PAG (n=9) or RVM (n=11), or intrathecally at the lumbar cord (n=4). In two animals, a naloxone-reversible antinociceptive effect was observed following the microinjection of 10 nmol BAM 22P into the RVM; however, no effect was seen in 3 animals microinjected with 20 nmol. Dyn A(1–13), a putative endogenous ligand for the κ receptor, had no antinociceptive effect when microinjected into the ventrolateral PAG, and no effect on the firing (spontaneous or noxious-evoked) of RVM On (n=3)- or Off (n=2)-Cells.

Reference (54)

  • HolltV. et al.

    Opioid peptides derived from pro-enkephalin A but not that from pro-enkephalin B are substantial analgesics after administration into brain of mice

    Eur. J. Pharmacol.

    (1982)
  • JensenT.S. et al.

    I. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in the rat

    Brain Research

    (1986)
  • JensenT.S. et al.

    Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique

    Brain Research

    (1986)
  • KanekoT. et al.

    Sites of analgesic action of dynorphin

    Life Sci.

    (1983)
  • KhachaturianH. et al.

    Dynorphin immunocytochemistry in the rat central nervous system

    Peptides

    (1982)
  • LewisV.A. et al.

    Evaluation of the periaqueductal gray as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci

    Brain Research

    (1977)
  • MizunoK. et al.

    A new family of endogenous ‘big’ met-enkephalins from bovine adrenal medulla: purification and structure of docosa(BAM22P)- and eicosapeptide (BAM20P) with very potent opiate activity

    Biophys. Res. Commun.

    (1980)
  • PierceyM.F. et al.

    U50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse

    Life Sci.

    (1982)
  • PrietoG.J. et al.

    Nucleus raphe magnus lesions disrupt stimulation-produced analgesia from ventral but not dorsal midbrain areas in the rat

    Brain Research

    (1983)
  • ProudfitH.K. et al.

    Morphine analgesia: blockade by raphe magnus lesions

    Brain Research

    (1975)
  • RenM.F. et al.

    Dynorphin A (1–13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord

    Peptides

    (1985)
  • SandkuhlerJ. et al.

    Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital-anesthetized rat

    Brain Research

    (1984)
  • SatohM. et al.

    Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats

    Life Sci.

    (1983)
  • SmithD.J. et al.

    The mu opiate receptor is responsible for descending pain inhibition

    Eur. J. Pharmacol.

    (1988)
  • VanegasH. et al.

    Midbrain stimulation inhibits tail-flick only at currents sufficient to excite rostral medullary neurons

    Brain Research

    (1984)
  • YakshT.L. et al.

    Chronic catheterization of the spinal subarachnoid space

    Physiol. Behav.

    (1976)
  • YakshT.L. et al.

    Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine

    Eur. J. Pharmacol.

    (1977)
  • Cited by (56)

    • Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction

      2021, International Review of Neurobiology
      Citation Excerpt :

      They differ in their analgesic or pro-nociceptive properties and their response to opioid agonists (Basbaum & Fields, 1984; Fang, Haws, Drasner, Williamson, & Fields, 1989). Briefly, MOR agonists inhibit ON cells while they disinhibit OFF cells to produce antinociception (Fang et al., 1989). The selective engagement of MOR in a cell type-specific fashion remains an unrealistic task for human chronic pain therapies, with perhaps the exception of intrathecal (spinal) pumps for cancer pain treatment.

    • Endogenous opioid peptides in the descending pain modulatory circuit

      2020, Neuropharmacology
      Citation Excerpt :

      However, outstanding questions remain in regard to the role of endogenous opioids in the PAG, including the role for endogenous opioids in regulating glutamatergic inputs and the temporal and spatial distribution of their release. In the rat, microinjections of opioids directly into the PAG elicit antinociception (Siuciak and Advokat, 1987; Tortorici and Morgan, 2002; Tortorici et al., 2001; Yaksh et al., 1976) through activation of MORs, not KORs (Fang et al., 1989). It is clear that activation of PAG output neurons leads to antinociception but the exact circuitry between these PAG output neurons and well-described populations of RVM neurons, namely RVM ON- and OFF-cells (Heinricher and Ingram, 2008), is not understood.

    • 5.15 - The Brainstem and Nociceptive Modulation

      2020, The Senses: A Comprehensive Reference: Volume 1-7, Second Edition
    • Inflammatory mediators of opioid tolerance: Implications for dependency and addiction

      2019, Peptides
      Citation Excerpt :

      Our results further suggest that solTNF mediates morphine tolerance in the PAG via TNFRI signaling and augmentation of glutamate homeostasis. Given that PAG-mediated analgesia depends largely on the ability of opioids to inhibit vlPAG MOR-expressing GABAergic neurons [12,19,22,39,43,47,65,162–186], our data suggest that TLR4 signaling contributes to opioid tolerance by decreasing the ability of morphine to hyperpolarize vlPAG GABAergic neurons, thereby maintaining tonic inhibition of vlPAG-RVM projections neurons, and preventing opioid analgesia. Glia modulation of opioid tolerance has been reported at every major level of the descending analgesic circuit: PAG, RVM, and spinal cord dorsal horn.

    • Networks for the Modulation of Acute and Chronic Pain

      2014, Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics
    • Medullary circuits for nociceptive modulation

      2012, Current Opinion in Neurobiology
      Citation Excerpt :

      Without question, the tonic effects of opioids on on and off cell discharge are dramatic in the anesthetized rat. On cells stop firing and off cells fire continuously after administration of an opioid at any dose and by any route that suppresses nociceptive withdrawals [see for example [10–13]]. The robust and consistent finding that opioids change the tonic firing of on and off cells led to the suggestion that the tonic discharge of on and off cells mediates RVM modulation of nociception.

    View all citing articles on Scopus
    View full text